Stock Analysis of Vascular Biogenics Ltd (VBLT) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code VBLT
Close 2.76
Change 2.60 / 1667.31 %
Volume 33121.00
Vol Change -5347.22 K / 99.38 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthBullish
Growth Index Very Low Growth Stock
Value Index Poor Value Stock
Profitability Index Very Low Profitability Stock
Stability Index Mild Stability


Fundamental View of Vascular Biogenics Ltd
PE (TTM)

18.63

Indecisive
Price / Book

8.62

Very Poor
Price / Sales

352.15

Very Poor
Piotroski F Score

1.0

Very Poor
Market Cap

214054 K

Enterprise Value

196953 K

ROA (TTM)

34.38

Excellent
ROE (TTM)

46.29

Very Good
Net Margin (TTM)

1890.07

Excellent
Revenue

14.32 %

658000
Net Profit

98.45 %

-464000.00
Debt to Equity

0.0251

Excellent
Altman Z Score

4.51

Very Good
Quick Ratio

3.10

Very Good
Cash Ratio

2.62

Good


Highs/Lows of Vascular Biogenics Ltd
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week0.156 1667.31 % 1.54 % 2.952.74506-Nov-2306-Nov-23
Two Week0.156 1667.31 % 3.42 % 2.952.74506-Nov-2306-Nov-23
One Month0.25 1002.80 % 5.60 % 2.950.152606-Nov-2316-Oct-23
Three Month0.2568 973.60 % 5.95 % 2.950.152606-Nov-2316-Oct-23
Six Months0.196 1306.63 % 17.48 % 2.950.152606-Nov-2316-Oct-23
One year0.125 2105.60 % 27.52 % 2.950.10106-Nov-2319-Dec-22
Two year2.43 13.46 % 29.70 % 2.950.10106-Nov-2319-Dec-22
Five year1.36 102.72 % 85.46 % 2.950.10106-Nov-2319-Dec-22


Technical View of Vascular Biogenics Ltd
RSI

95.32

Mild Bearish
MACD

0.194

Whipsaw
ADX

25.68

Bullish
Super Trend

1.92

Whipsaw
Williams %R

-6.90

Mild Bullish
CCI

666.67

Strong Bullish


EMA 5

1.05

Strong Bullish
EMA 15

0.535

Neutral
EMA 50

0.330

Whipsaw
EMA 100

0.282

Whipsaw
SMA 100

0.269

Whipsaw
SMA 200

0.218

Neutral
SMA 5 / 20

0.709 / 0.351

Neutral
SMA 15 / 50

0.397 / 0.279

Whipsaw
SMA 50 / 200

0.279 / 0.218

Bullish




Charts of Vascular Biogenics Ltd


Returns of Vascular Biogenics Ltd with Peers
Period / StockVBLTCLLSINMBRCEL
1 Week1667.31%-2.29%8.28%0.121%
1 Mth1002.80%21.54%28.71%-11.83%
3 Mth973.60%3.46%-22.56%-52.69%
6mth1306.63%2.05%46.42%-34.37%
1 Year2105.60%66.11%46.42%-32.16%
2 Year13.46%-14.08%44.86%46.37%
5 Years102.72%-83.99%0.277%-75.46%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Vascular Biogenics Ltd with Peers
Ratio / StockVBLTCLLSINMBRCEL
PE18.63-1.673818.41-4.72
P/B8.622.062237.873.62
ROA34.38-41.9441.20-47.78
ROE46.29-124.8959.27-77.06
Debt To Equity0.02510.4970.2690.0072
Revenue658000
14.32 % 		16496.00 K
13.95 % 		224000
159.89 % 		34421.00 K
%
Net Income-464000.00
98.45 % 		-85010.00 K
13.86 % 		-27433.00 K
0.491 % 		-26665.00 K
%


Technicals of Vascular Biogenics Ltd with Peers
Technical / StockVBLTCLLSINMBRCEL-
ADX25.6823.6415.2048.41
CMF-0.3110.4960.115-0.191
MFI34.4267.9543.7243.60
RSI95.3255.0750.3835.18
MACD Abv SignalTrueTrueTrueTrue
Price Above 50 MATrueTrueFalseFalse-
Price Above 200 MATrueTrueTrueFalse-


About : Vascular Biogenics Ltd

Address : 8 HaSatat Street, Hevel Modi'in, Israel, 7178106
Tel : 972 8 993 5000
URL : https://www.vblrx.com
Code : VBLT, ISIN : IL0011327454, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 01_Oct_2014
Employee Count : 7

Vascular Biogenics Ltd., a biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. It develops VB-601 using monocyte targeting technology for various inflammatory indications. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi'in, Israel.


Note : All Data Generated at the End of Trading Hours (EOD Data)